MC Healthcare signs partnership agreement with caresyntax to further automation, analytics and AI in hospital-based care

Jan 22, 2019

BOSTON, Oct. 30, 2018 /PRNewswire/ — Caresyntax, a surgical automation, analytics, and AI technology company, announced today that MC Healthcare, a subsidiary company of Mitsubishi Corporation, acquired a minority stake of caresyntax. This strategic investment of MC Healthcare will support business and technology development for caresyntax’s groundbreaking IoT and analytics solutions.

“We are delighted to be working with MC Healthcare, and we trust this partnership will help us to expand our technological leadership,” said Dennis Kogan, CEO of caresyntax. “We are especially gratified that a core healthcare subsidiary of multinational conglomerate of the size and reputation of Mitsubishi has acknowledged the value and potential of our advanced surgical data applications, which are already improving surgical care in more than 6,000 operating rooms worldwide.”

“We expect that caresyntax analytical solutions contribute the quality of medical treatment as well as the enhancement of hospital operations,” said Osamu Miyashita, CEO of MC Healthcare.

MC Healthcare, providing an integrated healthcare supply chain platform for hospitals, is serving about 250+ facilities in Japan. The company offers a wide variety of solutions such as a cost efficient procurement and inventory control of medical supply, running of a group purchasing organization (GPO), and importing cutting-edge medical devices from overseas for hospitals in Japan.

Functionally, the caresyntax platform integrates medical devices, electronic health records (EHRs), and other sources inside the OR, and aggregates the accumulated data inside of a unified dashboard to support a variety of surgical use cases. For example, automated case reporting allows surgeons to reduce time spent on manual documentation, while also generating a higher quality and structure of data to run analytics applications, such as video-based training or surgical risk calculation powered by AI. With a granular focus unique among data analytics products, caresyntax deciphers the causes of surgical performance variability and makes recommendations for fixing them, resulting in reduced readmissions, improved patient safety and better clinical workflows.

Caresyntax was launched in 2013 in Berlin – Germany, and established its full-time North American operations and headquarters in Boston in 2017.